No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MNKD240719C5500
- 0.20
- -0.12-37.50%
15min DelayClose Jul 19 15:59 ET
0.20High0.15Low
0.20Open0.32Pre Close141 Volume832 Open Interest5.50Strike Price2.69KTurnover647.38%IV-0.18%PremiumJul 19, 2024Expiry Date0.21Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.7270Delta0.8872Gamma20.76Leverage Ratio-1.6902Theta0.0000Rho15.10Eff Leverage0.0002Vega
Intraday
- 5D
- Daily
News
MannKind Corporation (NASDAQ:MNKD) Looks Inexpensive But Perhaps Not Attractive Enough
MannKind Corporation's (NASDAQ:MNKD) price-to-sales (or "P/S") ratio of 7.3x might make it look like a buy right now compared to the Biotechs industry in the United States, where around half of the
Is There An Opportunity With MannKind Corporation's (NASDAQ:MNKD) 49% Undervaluation?
All You Need to Know About MannKind (MNKD) Rating Upgrade to Buy
Is MannKind (MNKD) Outperforming Other Medical Stocks This Year?
Reported Earlier, MannKind's Inhaled Insulin Afrezza Shows Results in 17-Week Study
MannKind Corporation (NASDAQ:MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, today a
Express News | MannKind Corp: More People Met Glycemic Target of a1C (Less Than 7%) With Afrezza, Few Subjects Worsened Switching From Usual Care to Inhaled Insulin
Comments
I continue to hold a position in $MannKind(MNKD.US$ which is doing well. The company has a focus on metabolic diseases. I plan to sell the contracts in September (or when they hit my target percentage.) The shares I will hold for the time being, but may sell in favor of a basket such as the $Roundhill GLP-1 & Weight Loss ETF(OZEM.US$ ETF, depending whether MNKD continues to have attractive financials and whether I am willing to pay the management fee.
#Trading Journal
#Trading Journal
2
1
At 30% profit on calls, I will begin selling the contracts. The shares are a longterm hold and candidate for writing contracts.
4
Added to this position on a recent dip. Revenue and profit growth are such that I think this company may continue to perform over time (~34% annual growth past 5 years,) and be reflected in the share price.
3
I posted my shares position earlier and added to it today. Am including contracts as well as the ticker is on the move!
I am sharing positions that are new or currently active vs simply closed for profit in hopes it helps others with DD.
I am sharing positions that are new or currently active vs simply closed for profit in hopes it helps others with DD.
4
A newer position that I’ve been scaling into. Solid pipeline, and potential catalysts upcoming. I hold shares and calls.
2
Read more
I Am 102927471 :